홈/주식/EYPT

EYPT

USD

EyePoint Pharmaceuticals Inc. Common Stock

$12.390+0.260 (2.143%)

실시간 가격

Healthcare

생명공학

미국

가격 차트

Loading Chart...

핵심 지표

시장 지표

기업 기본 정보

거래 통계

시장 지표

시가

$12.130

고가

$12.950

저가

$11.960

거래량

4.59M

기업 기본 정보

시가총액

1.0B

산업

생명공학

국가

United States

거래 통계

평균 거래량

1.08M

거래소

NGM

통화

USD

52주 범위

저가 $3.91현재가 $12.390고가 $14.91

관련 뉴스

2025년 10월 15일 · 오전 02:43

GlobeNewswire

EyePoint Announces Pricing of Public Offering

WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with

EyePoint Announces Pricing of Public Offering

2025년 10월 14일 · 오후 08:35

GlobeNewswire

EyePoint Announces Proposed Public Offering of Common Stock

2025년 10월 14일 · 오후 08:01

GlobeNewswire

EyePoint Announces Pivotal Phase 3 Program Initiation for DURAVYU™ in Diabetic Macular Edema

– DURAVYU now in Phase 3 for the two largest, multi-billion-dollar retinal disease markets, wet AMD and DME with first patient dosing in pivotal Phase 3 DME trials anticipated in Q1 2026 – – New preclinical data

EyePoint Announces Pivotal Phase 3 Program Initiation for DURAVYU™ in Diabetic Macular Edema

관련 주식

METCB

Ramaco Resources Inc.

NASDAQ

석탄 채굴

BF/B

Brown Forman Corporation

NASDAQ

AGNCP

AGNC Investment Corp. Depositary Shares Each Representing a 1/1000th Interest in a Share of 6.125% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock

NASDAQ

부동산 투자 신탁